viernes, 17 de agosto de 2018

Emerging biomarkers in oncology research and practice

Emerging biomarkers in oncology research and practice

New Content Item



Emerging biomarkers in oncology research and practice

This thematic series of state-of-the-science publications covers cutting-edge developments in the field of oncology and pathology with reference to diagnostic, prognostic, predictive and pharmacodynamics biomarkers.
It includes articles on recent advances in discovery, methodology development, analytical and clinical validation and clinical qualification of novel tissue-based oncology biomarkers. Articles in the series also demonstrate the clinical utility and value of promising tissue-biomarkers in advancing the development of targeted therapeutics in oncology clinical trials and practice. 

The collection, guest edited by Dr. Aejaz Nasir, MD, MPhil, FCAP, is published in Cancer Cell International.
  1. Content Type:Primary Research

    Increasing data has indicated an association between increased soluble B7-H3 (sB7-H3) levels and unfavorable prognosis in patients with malignancies. However, the level of sB7-H3 and its clinical significance ...
    Authors:Ling Wang, Fu-biao Kang, Guo-chuan Zhang, Juan Wang, Ming-fang Xie and Ying-ze Zhang
    Citation:Cancer Cell International 2018 18:115
    Published on: 
  2. Content Type:Primary Research

    The aberrant regulation of MALAT1 has been indicated to be involved in various carcinogenic pathways contributing to the tumourigenesis and progression of cancers. The current meta-analysis summarized the rese...
    Authors:Juan Li, Zhigang Cui, Hang Li, Xiaoting Lv, Min Gao, Zitai Yang, Yanhong Bi, Ziwei Zhang, Shengli Wang, Baosen Zhou and Zhihua Yin
    Citation:Cancer Cell International 2018 18:109
    Published on: 
  3. Content Type:Primary Research

    Cancer-associated fibroblasts (CAFs) play important roles in tumor progression. However, the behaviors of activated CAFs in gastric cancer remain to be determined. The aim of the present study was to investiga...
    Authors:Yongchen Ma, Jing Zhu, Shanwen Chen, Tengyu Li, Ju Ma, Shihao Guo, Jianwen Hu, Taohua Yue, Junling Zhang, Pengyuan Wang, Xin Wang, Guowei Chen and Yucun Liu
    Citation:Cancer Cell International 2018 18:104
    Published on: 
  4. Content Type:Primary Research

    The expression of the immunoregulatory protein B7-H4 has been reported in many types of cancer, including breast cancer. However, its role in triple-negative breast cancer (TNBC), especially its correlation wi...
    Authors:Ling Wang, Chao Yang, Xin-bo Liu, Li Wang and Fu-biao Kang
    Citation:Cancer Cell International 2018 18:100
    Published on: 
  5. Content Type:Primary Research

    Ferulic acid (4-hydroxy-3-methoxycinnamic acid, FA) is a hydroxycinnamic acid derived from a rich polyphenolic compound. This study aimed to investigate the effect of ferulic acid (4-hydroxy-3-methoxycinnamic ...
    Authors:Jinhua Gao, Hui Yu, Weikang Guo, Ying Kong, lina Gu, Qi Li, Shanshan Yang, Yunyan Zhang and Yaoxian Wang
    Citation:Cancer Cell International 2018 18:102
    Published on: 
  6. Content Type:Review

    Gastro-esophageal adenocarcinomas (GEA) represent a severe global health burden and despite improvements in the multimodality treatment of these malignancies the prognosis of patients remains poor. HER2 overex...
    Authors:Francesca Battaglin, Madiha Naseem, Alberto Puccini and Heinz-Josef Lenz
    Citation:Cancer Cell International 2018 18:99
    Published on: 
  7. Content Type:Primary Research

    Breast cancer (BC) is the most frequent malignancy among females worldwide. Despite several efforts and improvements in early diagnosis and treatment, there are still tumors characterized by an aggressive beha...
    Authors:Jessica Iorio, Icro Meattini, Simonetta Bianchi, Marco Bernini, Virginia Maragna, Luca Dominici, Donato Casella, Vania Vezzosi, Lorenzo Orzalesi, Jacopo Nori, Lorenzo Livi, Annarosa Arcangeli and Elena Lastraioli
    Citation:Cancer Cell International 2018 18:93
    Published on: 
  8. Content Type:Primary Research

    Long non-coding RNAs play pivotal roles in the carcinogenesis of multiple types of cancers. This study is firstly to evaluate influence of rs4848320 and rs1110839 polymorphisms in long non-coding RNA AC016683....
    Authors:Juan Li, Hang Li, Xiaoting Lv, Zitai Yang, Min Gao, Yanhong Bi, Ziwei Zhang, Shengli Wang, Zhigang Cui, Baosen Zhou and Zhihua Yin
    Citation:Cancer Cell International 2018 18:91
    Published on: 
  9. Content Type:Primary Research

    Lung cancer is a leading public health issue worldwide. Although therapeutic approaches have improved drastically in the last decades, the prognosis of lung cancer patients remains suboptimal. The canonical nu...
    Authors:Hualong Qin, Jun Zhou, Jingjing Xu, Li Cheng, Zaixiang Tang, Haitao Ma and Feng Guo
    Citation:Cancer Cell International 2018 18:88
    Published on: 
  13. Content Type:Primary Research

    Meningioma cancer stem cells (MCSCs) contribute to tumor aggressiveness and drug resistance. Successful therapies developed for inoperable, recurrent, or metastatic tumors must target these cells and restrict ...
    Authors:Hanin Alamir, Mona Alomari, Abdulla Ahmed A. Salwati, Mohamad Saka, Mohammed Bangash, Saleh Baeesa, Fahad Alghamdi, Angel Carracedo, Hans-Juergen Schulten, Adeel Chaudhary, Adel Abuzenadah and Deema Hussein
    Citation:Cancer Cell International 2018 18:77
    Published on: 
  14. Content Type:Review

    The aberrant expression of long non-coding RNA (lncRNA) X inactivate-specific transcript (XIST) has been demonstrated to be involved in the tumourigenesis and the development of various cancers. Therefore, we ...
    Authors:Huihui Mao, Kai Wang, Yuehua Feng, Jun Zhang, Lili Pan, Yuxia Zhan, Haijun Sheng and Guanghua Luo
    Citation:Cancer Cell International 2018 18:34
    Published on: 
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)